Cargando…

Refractory multisystem sarcoidosis involving pelvic bone responding to infliximab

Detalles Bibliográficos
Autores principales:	Karjigi, Uma, Paul, Anupam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582434/ http://dx.doi.org/10.1186/1471-2474-14-S1-A9

Ejemplares similares

Unusual cause of hip pain
por: Karjigi, Uma, et al.
Publicado: (2013)

Acute polymyositis associated with hemophagocytic lymphohistiocytosis syndrome
por: Karjigi, Uma, et al.
Publicado: (2013)

Infliximab Treatment of Refractory Cardiac Sarcoidosis
por: Asawaeer, Majid, et al.
Publicado: (2020)

Uncommon osseous involvement in multisystemic sarcoidosis
por: Rajebi, Mohammad R., et al.
Publicado: (2009)

Urological involvements in pelvic oncologic surgery
por: Acconcia, A
Publicado: (2010)

A Case Series of Refractory Cutaneous Sarcoidosis Successfully Treated with Infliximab
por: Tuchinda, Papapit, et al.
Publicado: (2012)

Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis
por: Sakkat, Abdullah, et al.
Publicado: (2022)

P03-016 - ANTI IL1 refractory CINCA respondes to ANTI IL6
por: Dueckers, G, et al.
Publicado: (2013)

Refractory multisystemic sarcoidosis, a diagnosis and treatment challenge: a case report
por: Flores, Jorge Luis Rodas, et al.
Publicado: (2023)

The effect of infliximab on skin lesions in a patient with scleroderma (CREST)
por: De Rycke, L, et al.
Publicado: (2004)

Infliximab induced anti-dsDNA: characteristics of autoantibody response
por: Charles, PJ, et al.
Publicado: (2002)

Infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in a Japanese child
por: Yamaguchi, Yohei, et al.
Publicado: (2022)

The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies
por: van Damme, N, et al.
Publicado: (2002)

Infliximab-graded challenge in a patient with Crohn’s disease and adalimumab hypersensitivity
por: Song, Christine H, et al.
Publicado: (2012)

P03-013 - Symptomatic neuromuscular sarcoidosis
por: Mulazzani, M, et al.
Publicado: (2013)

Changes in rheumatoid factor reflect the inflammatory response (CRP and ESR) to infliximab treatment
por: De Rycke, L, et al.
Publicado: (2003)

Differential expression and response to infliximab treatment of specific macrophage subsets in inflammatory synovitis
por: De Rycke, L, et al.
Publicado: (2004)

The Great Imitator: A Case of Multisystem Sarcoidosis Involving the Genitourinary System
por: Alhashimalsayed, Zaki, et al.
Publicado: (2023)

Circulating bioactive TNF in rheumatoid arthritis patients treated with infliximab: link to clinical response
por: Marotte, H, et al.
Publicado: (2003)

Shared epitope and rheumatoid arthritis severity: association with infliximab treatment in a postmarketing study
por: Marotte, H, et al.
Publicado: (2003)

Lactic acid clearance in the emergency department prognosticates multisystem organ failure and death
por: Knoblich, BP, et al.
Publicado: (2000)

Polymorphism at the position -308 of TNF-α gene influences outcome of infliximab therapy in rheumatoid arthritis
por: Mugnier, B, et al.
Publicado: (2004)

Systemic sarcoidosis with bone marrow involvement responding to therapy with adalimumab: a case report
por: Patel, Supen R
Publicado: (2009)

Infliximab treatment reduces synovial cellularity as early as 48 hours after initiation of treatment, but not by induction of apoptosis
por: Smeets, TJM, et al.
Publicado: (2003)

Simultaneous development of sarcoidosis and cutaneous vasculitis in a patient with refractory Crohn’s disease during infliximab therapy
por: Numakura, Tadahisa, et al.
Publicado: (2016)

Pediatric Gastrointestinal Sarcoidosis: Successful Treatment with Infliximab
por: Alawdah, Laila, et al.
Publicado: (2016)

P03-013-B - Inaugural palate nodule of a systemic sarcoidosis
por: Mael-Ainin, M, et al.
Publicado: (2013)

Induction of ANA, anti-dsDNA and anti-nucleosome antibodies following infliximab treatment in rheumatoid arthritis and spondyloarthropathy patients
por: de Rycke, LEB, et al.
Publicado: (2002)

Palpitations as a presenting feature of multisystem sarcoidosis
por: Manikat, Richie, et al.
Publicado: (2017)

Bone and Bone Marrow Involvement in Sarcoidosis
por: Sargın, Gökhan, et al.
Publicado: (2014)

Sarcoidosis secondary to lymphocyte active immunotherapy treated with infliximab
por: de Souza, Gabriela Higino, et al.
Publicado: (2018)

Treating sarcoidosis-associated progressive multifocal leukoencephalopathy with infliximab
por: Rosenkranz, Sina C., et al.
Publicado: (2021)

Effects of omalizumab on chronic urticaria not responding to recommended therapy
por: Hébert, Jacques, et al.
Publicado: (2012)

Hypothermia in refractory status epilepticus
por: Rossetti, Andrea O
Publicado: (2012)

Infliximab for the treatment of refractory scleritis
por: Doctor, Priyanka, et al.
Publicado: (2009)

P01-002 – Comparison between different colchicines responders
por: Özçakar, ZB, et al.
Publicado: (2013)

Alveolar recruitment improves arterial oxygenation in responders to prone position
por: Reutershan, J, et al.
Publicado: (2002)

Budd-Chiari Syndrome: An Unusual Presentation of Multisystemic Sarcoidosis
por: Ennaifer, Rym, et al.
Publicado: (2015)

Multisystemic Sarcoidosis Revealed by Hepatosplenomegaly: A Case Report
por: El Rhaoussi, Fatima Zahra, et al.
Publicado: (2022)

MULTISYSTEM SARCOIDOSIS ASSOCIATED WITH THE COVID-19 MRNA VACCINE
por: MITMA, ANGEL A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3j3lqgock9gockasfd10kgfli0